Cowen analyst Yaron Werber lowered the firm’s price target on Amgen to $289 from $307 and keeps an Outperform rating on the shares. The analyst said Q4 beat on revs/EPS despite multiple legacy franchises looking light while 23 guidance looks appropriately conservative to account for biosimilar competition.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on AMGN: